Its really quite incredible to have similar A1C lowering effects with weight loss and very little hypoglycemia," Billings said
Jensen SBK, Srensen V, Sandsdal RM, et al
314,6008 (1985): 281-3./ Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI
Beyond GLP-1: efficacy and safety of dual and triple incretin agonists in personalized type 2 diabetes care-a systematic review and network meta-analysis
While other publications from the group remain intact, the retraction introduces uncertainty about the reliability of some mechanistic claims and demands particular caution in interpreting the overall evidence base
Tirzepatide cost varies a lot between research-grade and prescription Mounjaro / Zepbound channels